Video – INSIGHT 2: A Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance حسب Taylor & Francis (465068)

DataSheet_1_Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.pdf حسب Sunisa Prasopporn (12553843)

الموضوعات:

DataSheet_1_Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma.pdf حسب Sunisa Prasopporn (12553843)

الموضوعات:

DataSheet_1_Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI.pdf حسب Haiyi Deng (10909299)

"…</p>Methods<p>This retrospective study included patients with mutation-positive NSCLC after developing resistance to EGFR-TKIs. Patients who received chemotherapy alone plus ICIs with or without anti-angiogenic drugs (cohort A) or platinum-based chemotherapy (cohort B) between February 2019 and August 2020 were enrolled. …"

The Cox proportional analysis of parameter fitting using <i>all-line fitting</i> from the SR and R0 model. حسب Kanyarat Jitmana (18693060)

الموضوعات:

Cox proportional analysis of parameter fitting using <i>two-line fitting</i> with the SR and R0 model. حسب Kanyarat Jitmana (18693060)

الموضوعات:

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for TKIs-resistant, EGFR-mutant, advanced non-small-cell lung cancer: a phase 3 RCTs based meta-analysis حسب Xi Chen (35903)

"…<p>Immunotherapy combined with chemotherapy has emerged as a potential strategy to overcome tyrosine kinase inhibitors (TKIs)-resistant for advanced non-small-cell lung cancer (NSCLC); however, the efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy (PIC) compared to chemotherapy alone require further investigation.…"

Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient. Supplementary Tables حسب Qing Xu (71204)

DataSheet_1_RETRACTED: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf حسب Bo Li (112195)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Syndecan ectodomain fragments decrease endothelial resistance via rho kinase. حسب Melanie Jannaway (6703577)

Supplementary Table 1 - FON-2021-1406 - INSIGHT 2: A Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance حسب Egbert F Smit (9252899)

Table_1_A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports.docx حسب Bin-Ru Wang (10358697)

DataSheet_1_Shading decreases lodging resistance of wheat under different planting densities by altering lignin monomer composition of stems.docx حسب Yongli Luo (2802727)

"…<p>To clarify the influences of shading stress and planting density on the lignin monomer composition of wheat stems and their relationship with lodging resistance, Lodging resistant variety Shannong 23 (SN23) and lodging sensitive variety Shannong 16 (SN16) were grown during 2018−2019 and 2019−2020 growing seasons. …"

Decreased sensitivity to Thaxtomin A (TA) in TA-habituated somaclone RB9. حسب Nathalie Beaudoin (21537)

Table_1_Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient.docx حسب Li Wang (15202)

"…This case not only highlights the importance of irAE management in patients treated with camrelizumab, but also demonstrates the potential of PD-1 antibody plus trastuzumab in HER2-positive GBC patients who have developed resistance to chemotherapy and trastuzumab-based targeted therapy.…"

Supplementing NAD+ counters the effects of Oxamate on metabolism and chemotherapy sensitivity. حسب Siyu Yuan (7425719)

الموضوعات:

Image_1_Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report.jpeg حسب Dan Li (106345)

Image_1_Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy.tif حسب Guoqing Zhang (151441)

Image_2_Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia.tif حسب Li Wang (15202)

"…However, the relationship between Nrf2 and Vincristine (VCR) chemotherapy resistance in B-cell acute lymphoblastic leukemia (B-ALL) is not yet established. …"